Home » Topics » Regulatory » Patents

Patents
RSS

Idorsia Pharmaceuticals discovers Kv7 potassium channel activators

Jan. 19, 2022

Universite de Franche-Comte presents compounds targeting histamine H3 receptors

Jan. 18, 2022

Purdue Research Foundation patents protein kinase inhibitors

Jan. 18, 2022

Viral replication inhibitors patented by Gilead

Jan. 17, 2022

New glucocorticoid receptor antagonists discovered at Corcept Therapeutics

Jan. 17, 2022

Celgene presents new cereblon-binding PROTACs

Jan. 17, 2022

New GLP-1 receptor agonists identified at Guangzhou Henovcom Bioscience

Jan. 17, 2022

BeiGene discloses non-receptor tyrosine-protein kinase TYK2 inhibitors

Jan. 17, 2022

BioWorld MedTech Patent Highlights: Week 1

From Current Patent Gazette

Jan. 14, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Sage Therapeutics discloses new GABA-A receptor modulators

Jan. 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...